SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-18-007101
Filing Date
2018-06-28
Accepted
2018-06-28 16:30:45
Documents
4
Period of Report
2018-06-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT cdxc8k_june222018.htm 8-K 77217
2 AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT, DATED JUNE 22, 2018, BY AND ex10-1.htm EX-10.1 90053
3 AMENDMENT, DATED JUNE 22, 2018, TO THE AMENDED AND RESTATED EMPLOYMENT AGREEMENT ex10-2.htm EX-10.2 15366
4 CHROMADEX CORPORATION 2017 EQUITY INCENTIVE PLAN, AS AMENDED ex99-1.htm EX-99.1 441029
  Complete submission text file 0001654954-18-007101.txt   625092
Mailing Address 10005 MUIRLANDS BLVD. STE. G, FIRST FLOOR IRVINE CA 92618
Business Address 10005 MUIRLANDS BLVD. STE. G, FIRST FLOOR IRVINE CA 92618 949-419-0288
ChromaDex Corp. (Filer) CIK: 0001386570 (see all company filings)

IRS No.: 262940963 | State of Incorp.: DE | Fiscal Year End: 1229
Type: 8-K | Act: 34 | File No.: 001-37752 | Film No.: 18925713
SIC: 2833 Medicinal Chemicals & Botanical Products